Sutro Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- Sutro Biopharma's estimated annual revenue is currently $76.2M per year.
- Sutro Biopharma's estimated revenue per employee is $217,000
- Sutro Biopharma's total funding is $346.6M.
Employee Data
- Sutro Biopharma has 351 Employees.
- Sutro Biopharma grew their employee count by 4% last year.
Sutro Biopharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | VP, Research | Reveal Email/Phone |
5 | VP, CMC & Supply Chain | Reveal Email/Phone |
6 | SVP, Quality | Reveal Email/Phone |
7 | VP, Clinical Operations | Reveal Email/Phone |
8 | Head Strategic CMO Alliances, Europe | Reveal Email/Phone |
9 | VP Information Technology & Facilities Operations | Reveal Email/Phone |
10 | VP Finance | Reveal Email/Phone |
Sutro Biopharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Sutro Biopharma?
Sutro Biopharma is a biopharmaceutical company that develops and designs novel protein therapeutics and biosuperiors that have site-directed modifications, including modifications incorporating non-natural amino acids. Sutro's biochemical protein synthesis technology opens up opportunities to create protein therapeutics that cannot be produced using conventional methods. Sutro?s technology enables the rapid and systematic exploration of many protein drug variants to identify drug candidates. Once identified, the company can efficiently scale production to commercial levels. In addition to developing its own drug pipeline, Sutro is collaborating with select pharmaceutical and biotechnology companies in the development of novel protein therapeutics that cannot be designed, produced or studied with current technologies.
keywords:N/A
$346.6M
Total Funding
351
Number of Employees
$76.2M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sutro Biopharma News
Equities analysts forecast that Sutro Biopharma, Inc. (NASDAQ:STRO Get Rating) will post sales of $11.48 million for the current quarter,...
Sutro Biopharma has a 12-month low of $7.20 and a 12-month high of $23.70. The firm has a market cap of $336.73 million, a P/E ratio of -3.17...
Sutro Biopharma, Inc., located in South San Francisco, is a clinical-stage drug discovery, development and manufacturing company. Using precise...
SOUTH SAN FRANCISCO, Nov. 17, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeuti ...
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune t ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $79M | 351 | 5% | N/A |
#2 | $79M | 351 | 14% | N/A |
#3 | $15M | 351 | -32% | N/A |
#4 | $107.5M | 351 | 3% | N/A |
#5 | $89.9M | 351 | 9% | N/A |